Prediction of GFR in liver transplant candidates.

BACKGROUND Kidney function frequently is impaired in patients with cirrhosis; however, glomerular filtration rate (GFR) is difficult to estimate in these patients by using standard clinical markers. The aim of our study is to compare GFR calculated from renal clearance of iodine 125-labeled iothalamate ((125)I-iothalamate) with the plasma decay technique and the Modification of Diet in Renal Disease (MDRD) and Cockroft-Gault (CG) prediction equations. METHODS We performed a cross-sectional study of patients with liver cirrhosis being evaluated for transplantation (50% Child's class C); 89% had ascites or edema and 44% were men aged 55 +/- 2 years. Average pretest blood urea nitrogen level was 16 +/- 2 mg/dL (5.7 +/- 0.7 mmol/L); serum creatinine, 1.0 +/- 0.1 mg/dL (88 +/- 9 micromol/L; range, 0.6 to 1.7 mg/dL [53 to 150 micromol/L]); plasma albumin, 3.14 +/- 0.16 g/dL (31.4 +/- 1.6 g/L); and total bilirubin, 4.0 +/- 0.7 mg/dL (67 +/- 11.3 micromol/L). Kidney function was measured by means of simultaneous plasma and renal clearance of (125)I-iothalamate (Glofil-125; Cypros Pharmaceutical Corp, Carlsbad, CA) and the MDRD and CG equations. RESULTS GFRs were 58.2 +/- 5.1 mL/min/1.73 m(2) by renal clearance of (125)I-iothalamate and 76.7 +/- 7.2 mL/min/1.73 m(2) by the plasma decay technique (+18.5 mL/min, or 32%; P = 0.0004). GFR by the MDRD equation was 76.9 +/- 7.8 mL/min/1.73 m(2) (+18.7 mL/min, or 32%; P = 0.0004 versus renal iothalamate; r(2) = 0.57). GFR by the CG equation was the least accurate (+30.1 mL/min, or 52%; P = 0.0001 versus renal iothalamate). CONCLUSION The current clinically used CG and MDRD equations to estimate kidney function in patients with cirrhosis and volume excess and the (125)I-iothalamate plasma decay technique are inaccurate because they overestimate GFR. It seems very unlikely that accurate and reliable formulas will be developed that are able to replace the formal measurement of GFR in patients with liver cirrhosis. Therefore, we conclude that despite the additional complexity, renal clearance techniques should be used to assess GFR accurately in patients with liver cirrhosis and ascites.

[1]  D. Fish,et al.  Assessing renal function in cirrhotic patients: problems and pitfalls. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  J. Lewis,et al.  Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[4]  R. Frye,et al.  Comparison of Iothalamate Clearance Methods for Measuring GFR , 1999, Pharmacotherapy.

[5]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[6]  A. Hughes,et al.  Direct vascular effects of furosemide in humans. , 1997, Circulation.

[7]  N. Perico,et al.  Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. , 1995, Journal of the American Society of Nephrology : JASN.

[8]  G. Klintmalm,et al.  Impact of pretransplant renal function on survival after liver transplantation. , 1995 .

[9]  P. Angeli,et al.  Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. , 1994, Archives of internal medicine.

[10]  Paul E. Teschan,et al.  Glomerular filtration rate measurements in clinical trials , 1993 .

[11]  Y. Isaka,et al.  Modified plasma clearance technique using nonradioactive iothalamate for measuring GFR. , 1992, Kidney international.

[12]  G. Beck,et al.  Utility of Radioisotopic Filtration Markers in Chronic Renal Issufficiency: Simultaneous Comparison of 125I-Iothalamate, 169Yb-DTPA, 99mTc-DTPA, and Inulin , 1990 .

[13]  A. Levey.  Use of glomerular filtration rate measurements to assess the progression of renal disease. , 1989, Seminars in nephrology.

[14]  B. Myers,et al.  Cyclosporine-associated chronic nephropathy. , 1984, The New England journal of medicine.

[15]  F. Iber,et al.  Hepatology: A Textbook of Liver Disease , 1983 .

[16]  D. Cocchetto,et al.  Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. , 1983, Therapeutic drug monitoring.

[17]  J. Henriksen,et al.  Over-estimation of glomerular filtration rate by single injection [51Cr]EDTA plasma clearance determination in patients with ascites. , 1980, Scandinavian journal of clinical and laboratory investigation.

[18]  J. Brøchner-Mortensen,et al.  Routine methods and their reliability for assessment of glomerular filtration rate in adults, with special reference to total [51Cr]EDTA plasma clearance. , 1978, Danish medical bulletin.

[19]  I. Osberg,et al.  Bilirubin interference with the kinetic Jaffé method for serum creatinine. , 1978, Clinical chemistry.

[20]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[21]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[22]  J. Bröchner-Mortensen,et al.  Renal inulin clearance versus total plasma clearance of 51Cr-EDTA. , 1969, Scandinavian journal of clinical and laboratory investigation.

[23]  S. Saunders,et al.  Treatment of hepatic coma by exchange blood transfusion. , 1966, The New England journal of medicine.